Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9281803 | 1.00 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL4557966 | 1.00 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL6435438 | 0.89 | SMN1; SMN2 (0.52) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL6435439 | 0.89 | SMN1; SMN2 (0.52) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL4318714 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL239953 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL239954 | 0.80 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| Acrylamide SCHEMBL9362700 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRMAPTSMN1; SMN2RAB9A | |
| SCHEMBL307121 | 0.76 | — | — | |
| SCHEMBL10499492 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070275869-A1 | Polysaccharide Derivatives, Their Production and Use | BIOGHURT BIOGARDE GMBH & CO., KG (DE) | 2007-11-29 | — | — | US | claimed |
| US-20070275869-A1 | Polysaccharide Derivatives, Their Production and Use | BIOGHURT BIOGARDE GMBH & CO., KG (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20020119171-A1 | COPOLYMERIC HYDROPHOBICALLY MODIFIED POLYASPARTIC ESTER AMIDES AND THEIR USE | GOLDSCHMIDT AG (DE) | 2002-08-29 | — | — | US | disclosed |
| EP-0155567-B1 | LIGHT-TRANSMITTING FIBER | MITSUBISHI RAYON CO., LTD. (JP) | 1991-12-04 | — | — | EP | disclosed |
| US-4693553-A | Light-transmitting fiber | MITSUBISHI RAYON COMPANY LTD. (JP) | 1987-09-15 | — | — | US | disclosed |
| US-4464506-A | COPOLYMER OF VINYL ORGANOSILOXANE, SI-H GROUP ORGANOSILOXANE, AND ADDITIONAL MONOMER | BAYER AKTIENGESELLSCHAFT (DE) | 1984-08-07 | — | — | US | disclosed |
| US-4463127-A | Crosslinkable graft polymer dispersion of organopolysiloxanes containing hydrogen-siloxane groups and Si-vinyl groups | BAYER AKTIENGESELLSCHAFT (DE) | 1984-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119171-A1 | COPOLYMERIC HYDROPHOBICALLY MODIFIED POLYASPARTIC ESTER AMIDES AND THEIR USE | ARGLU1, ARG1, SLC7A1 | ALDH1A1 3048/4885TSHR 1380/4885MAPT 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.